Tuesday, November 5, 2024
Subscribe American Journal of Medicine Free Newsletter
American Journal of MedicineCME Course Updates Physicians on Parkinson’s Disease Care

CME Course Updates Physicians on Parkinson’s Disease Care

CMEThe American Journal of Medicine has a new continuing medical education (CME) course on Parkinson’s disease on our website:

An Update on Parkinson’s Disease: Improving Patient Outcomes

Neurologists are faced with many challenges in caring for patients with Parkinson’s disease (PD). This chronic, long-term illness that affects at least one million people in the United States requires a coordinated healthcare partnership between the physician and the patient. The importance of early diagnosis is essential to delaying disease progression and early diagnosis and intervention may be aided by recent advances in biomarkers, genomics, and imaging. A misdiagnosis or late diagnosis will lead to deteriorating patient health. Additionally, physicians should incorporate current guidelines into their treatment strategies, and awareness of the reasoning behind these guidelines is critical for appropriate use. Physicians should be up to date on identifying the most appropriate therapies based on emerging science and disease staging, and should implement patient education into their practice. Due to limitations for currently available therapies, adjunctive therapies may lead to improved outcomes in patients with PD. The use of multiple therapies can improve a myriad of symptoms, more so than a monotherapy. Knowledge of these therapies is critical to achieving best outcomes in patients with PD.

This webcast will discuss the current challenges with PD clinical practice, clinical features of PD, the impact of treatment, future treatments for PD and improving patient outcomes.

Target Audience

Neurologists, internists, primary care providers and healthcare professionals responsible for the diagnosis, treatment or management of patients with Parkinson ’s disease (PD).

Educational Objectives

Upon completion of this activity, participants will be able to:

  1. Incorporate early diagnosis, early intervention, and current treatment guidelines into the care of patients with PD
  2. Apply the recent clinical trial data of current and emerging therapies to the management of patients with PD
  3. Discuss the risks and benefits of adjunct therapies in PD

Follow this link to learn more or to log on to the CME course.

Latest Posts

lupus

Sarcoidosis with Lupus Pernio in an Afro-Caribbean Man

A 54-year-old man of Afro-Caribbean ancestry presented with a 2-month history of nonproductive cough, 10-day history of constant subjective fevers, and a 1-day history...
Flue Vaccine

Flu Vaccination to Prevent Cardiovascular Mortality (video)

0
"Influenza can cause a significant burden on patients with coronary artery disease," write Barbetta et al in The American Journal of Medicine. For this...
varicella zoster

Varicella Zoster Virus-Induced Complete Heart Block

0
Complete heart block is usually caused by chronic myocardial ischemia and fibrosis but can also be induced by bacterial and viral infections. The varicella...
Racial justice in healthcare

Teaching Anti-Racism in the Clinical Environment

0
"Teaching Anti-Racism in the Clinical Environment: The Five-Minute Moment for Racial Justice in Healthcare" was originally published in the April 2023 issue of The...
Invisible hand of the market

The ‘Invisible Hand’ Doesn’t Work for Prescription Drugs

0
Pharmaceutical innovation has been responsible for many “miracles of modern medicine.” Reliance on the “invisible hand” of Adam Smith to allocate resources in the...
Joseph S. Alpert, MD

New Coronary Heart Disease Risk Factors

0
"New Coronary Heart Disease Risk Factors" by AJM Editor-in Chief Joseph S. Alpert, MD was originally published in the April 2023 issue of The...
Cardiovascular risk from noncardiac activities

Cardiac Risk Related to Noncardiac & Nonsurgical Activities

0
"Assessment of Cardiovascular Risk for Noncardiac and Nonsurgical Activities" was originally published in the April 2023 issue of The American Journal of Medicine. Cardiovascular risk...